Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon
Phase of Trial: Phase IV
Latest Information Update: 16 Mar 2017
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Acronyms INFLUENCE
- Sponsors Bayer
- 29 Apr 2016 Status changed from active, no longer recruiting to completed.
- 26 Oct 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 26 Oct 2015 Planned End Date changed from 1 Dec 2015 to 1 Jan 2016 as per ClinicalTrials.gov record.